Scientific Sessions and Hot Topics:
translation from experiments to treatment strategies: from gut microbiome to blood-brain-barrier and glial and B-cell phenotypes/interactions
pediatric and adult MS and related disorders, immunosenescence, treatment aspects, definition/monitoring disease progression,
about (epi-) genetics, biomarkers, molecular and advanced imaging methods, and biosensors
COVID-19 & MS, real-world-evidence data, patients’ perspectives and global networks
e.g. differential diagnosis, radiological isolated syndrome, MRI in clinical practice, vaccines, quality standards for biomarkers
The preliminary scientific programme will be available in spring 2021.